| Literature DB >> 30455734 |
Changqing Liu1,2, Kai Zhang1,2, Wenyan Cao1,2, Ge Zhang1,2,3, Guoqiang Chen1,2,3, Haiyan Yang1,2, Qian Wang3, Haobao Liu3, Mo Xian1,2, Haibo Zhang1,2.
Abstract
BACKGROUND: 2-Phenylethanol (2-PE) is a higher aromatic alcohol that is widely used in the perfumery, cosmetics, and food industries and is also a potentially valuable next-generation biofuel. In our previous study, a new strain Enterobacter sp. CGMCC 5087 was isolated to produce 2-PE from glucose through the phenylpyruvate pathway.Entities:
Keywords: 2-Keto acid decarboxylase; 2-Phenylethanol; Alcohol dehydrogenase; Enterobacter sp. CGMCC 5087; Metabolic engineering; Phenylpyruvate pathway
Year: 2018 PMID: 30455734 PMCID: PMC6223000 DOI: 10.1186/s13068-018-1297-3
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1Synthetic route of 2-PE. A 2-PE chemical synthesis. a Friedel–Craft reaction of ethylene oxide. b Catalytic reduction of styrene oxide. B 2-PE biosynthesis in E. coli. Metabolite abbreviations: PTS, phosphotransferase system; G6P, glucose 6-phosphate; F6P, fructose-6-phosphate; F16BP, fructose-1,6-diphosphate; GAP, glyceraldehyde-3-phosphate; PEP, phosphoenolpyruvate; R5P, ribose-5-phosphate; Xu5P, ribulose-5-phosphate; STP, sedoheptulose-7-phosphate; E4P, erythrose 4-phosphate; DAHP, 3-deoxy-d-arabino-heptulosonate-7-phosphate; DHQ, 3-dehydroquinate; DHS, 3-dehydro-shikimate; SHK, shikimate; S3P, shikimate-3-phosphate; EPSP, 5-enolpyruvylshikimate-3-phosphate; CHA, chorismate; PPA, prephenate; PPY, phenylpyruvate; PPAL, phenylacetaldehyde; PEA, phenylethylamine; l-Phe, l-phenylalanine; l-Tyr, l-tyrosine; l-Trp, l-tryptophan. Genes and enzymes: zwf, glucose 6-phosphate dehydrogenase; pgi, glucose 6-phosphate isomerase; fbaA, fructose-1,6-diphosphate aldolase; pykA, pyruvate kinase II; pykF, pyruvate kinase I; ppsA, phosphoenolpyruvate synthase; tktA, transketolase; talB, transaldolase B; aroG, DAHP synthetase feedback inhibited by Phe; aroH, DAHP synthetase feedback inhibited by Trp; aroF, DAHP synthetase feedback inhibited by Tyr; aroB, 3-dehydroquinate synthase; aroD, 3-dehydroquinate dehydratase; aroE, shikimate dehydrogenase; aroL, shikimate kinase 2; aroK, Shikimate kinase 1; aroA, 3-phosphoshikimate 1-carboxyvinyltransferase; aroC, chorismate synthase; pheA, fused chorismate mutase and prephenate dehydratase; tyrB, aromatic-amino-acid aminotransferase; AADC, aromatic amino acid decarboxylase; MAO, amine oxidase; KDC, alpha-keto-acid decarboxylase; Adh, alcohol dehydrogenase; PAAS, phenylacetaldehyde synthase; TCA cycle, tricarboxylic acid cycle
Fig. 2Genome sequencing results for Enterobacter sp. CGMCC 5087. a Gene length distribution map. b Correlation analysis of GC content and depth
Fig. 3Validation of 2-PE biosynthesis by engineered E. coli. a Engineered E. coli was cultured in LB medium and detected with GC–MS; b Graph of GC; c graph of GC–MS
Fig. 4Characterization of Kdc4427 and Adh4428. A Characterization of Kdc4427 and comparison with corresponding ARO10. a E. coli BL09 and E. coli BL11 cells were cultivated, and their cell growth (OD600) and 2-PE production titers were compared. b Phenylpyruvate decarboxylase from Kdc4427 and ARO10 in recombinant E. coli BL21(DE3) whole cells. The conversion of 1 g/L phenylpyruvate to 2-PE. B Characterization of Adh4428 and comparison with corresponding ADH2. a E. coli BL12 and E. coli BL09 cells were cultivated, and their cell growth (OD600) and 2-PE production titers were compared. b Phenylpyruvate dehydrogenase from Adh4428 and ADH2 in recombinant E. coli BL21(DE3) whole cells. The conversion of 1 g/L phenylacetaldehyde to 2-PE
Fig. 5Effects of the overexpression of key upstream genes on 2-PE production. a Effect of l-Phe addition on 2-PE production. b Effects of the overexpression of candidate aroF/aroG/aroH and pheA genes on 2-PE production. Engineered E. coli cells were cultivated, and 2-PE production titers were compared. c Effects of overexpression of the aroF, pheA, ppsA, and tktA genes on 2-PE production. Engineered E. coli cells were cultivated and 2-PE production titers were compared
Fig. 6Tolerance of E. coli BL21(DE3) cells to 2-PE toxicity. Growth response of E. coli BL21(DE3) cells to 0, 0.5 g/L, 1.0 g/L, 1.5 g/L, 2.0 g/L 2-PE in LB medium. Error bars represent one standard deviation from triplicate experiments
Fig. 7General flow chart of this study
Plasmids and strains used in this study
| Name | Relevant characteristics | References |
|---|---|---|
| Plasmids | ||
| pETDuet-1 | ColE1(pBR322) ori; Ampr; PT7 | Novagen |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | Reference [ |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pTrcHis2B- | pBR322 ori; Ampr; PTrc- | Reference [ |
| pETDuet- | ColE1(pBR322) ori; Ampr; PT7- | This work |
| pACYCDuet-1 | P15A origin; CmR; PT7 | Novagen |
| pACYCduet- | P15A origin; CmR; PT7- | This work |
| pACYCduet- | P15A origin; CmR; PT7- | This work |
| pACYCduet- | P15A origin; CmR; PT7- | This work |
| Strains | ||
| | Takara | |
| | Invitrogen | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
| | This work | |
Primers used in this study
| Primers | Nucleotide sequencea |
|---|---|
| pETDuet- | CGCggatcctATGAATCACATGAATAAAC |
| pETDuet- | CCCaagcttATGCGCTTGTAAGACC |
| pETDuet- | CGCggatcctGTGGCAAAAGTGGAACCCG |
| pETDuet- | cgaattcTCATGCCATCCCCTTCGC |
| pETDuet- | CGCggatcctATGAAACGACTCATTGTTGG |
| pETDuet- | CCCaagcttCAGGCCCCTTGCCAGCG |
| pETDuet- | CGCggatcctATGAACACCTTCGACAAAC |
| pETDuet- | CCCaagcttACAGGTTATCTGGAAAG |
| pETDuet- | CGCggatcctATGACGGGGGCAACGGGC |
| pETDuet- | CCCaagcttCAAATGCCATCTTTATTCTC |
| pETDuet- | CGCggatcctATGGCATTTGATGATTTGAG |
| pETDuet- | cagagctcTTATTGACGTGCTGCCAGC |
| pETDuet- | CGCggatcctATGATTTGTCCACGTTGTGC |
| pETDuet- | CCCaagcttACAGCAGCGGCGGGATTG |
| pETDuet- | CGCggatcctATGATTAAATCATTAACGTCC |
| pETDuet- | cgaattcTCAATCTGCGGAAATGGC |
| pETDuet- | CGCggatcctATGCGTACCCCATACTGC |
| pETDuet- | ATAAGAATgcggccgcCAGGCGCTATTGCGCGC |
| pETDuet- | CGCggatcctATGGCACCTGTTACAATTG |
| pETDuet- | cagagctCTATTTTTTATTTCTTTTAAGTG |
| pACYC- | catcagatctccatcaccatcatcaccacATGTCTATTCCAGAAACTC |
| pACYC- | cggggtaccTTATTTAGAAGTGTCAAC |
| pACYC- | GAagatctCATGGGTTATCAGCCGGACA |
| pACYC- | CCGctcgagTTATTTTGAGCTGTTCAGGATTG |
| GA agatctc ATGACACCGGAAAACCCGTTAC | |
| CCGctcgag TTAGGCCGGGTCAACCG | |
| GA agatctc ATGGTTGCTGAATTGACCG | |
| CCGctcgag TTACTGGCGACTGTCATTTG | |
| GCggatcctATGAATTATCAGAACGACGATTTACGCAT | |
| ATAAGAATgcggccgcTTAGCCGCGACGCGCTTTTA | |
| GCggatcctATGAATAAAACCGATGAACTCCG | |
| ATAAGAATgcggccgcTTAGAAGCGAGAATCAACCG | |
| GCg gat cct TTGAGGAAAACAACTATCGCA | |
| ATAAGAATgcggccgc TTAAGCCAGACGCGTCG | |
| TCCGctcgagTTAAGGAGGTATATATTAATGTCCAACAATGGCTCGT | |
| TCCGcctaggTTACAGCAGTTCTTTTGCTTTCG |